Zunsemetinib [CAS 1640282-42-3]
Partner: MedChemexpress LLC
| CAS No: | 1640282-42-3 |
| Applications: | COVID-19-immunoregulation |
| MW: | 513.92 |
| Formula: | C25H22ClF2N5O3 |
| SMILES: | FC1=CC(F)=CN=C1COC2=C(Cl)C(N(C3=CC(C4=NC(C(C)(C)O)=NC=C4)=NC=C3C)C(C)=C2)=O |
| Purity: | 99.37 |
| Description: | Zunsemetinib (CDD-450) is an orally active and selective p38? mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
